
Chinese General Practice ›› 2026, Vol. 29 ›› Issue (01): 91-99.DOI: 10.12114/j.issn.1007-9572.2024.0671
Special Issue: 高血压最新文章合辑; 心血管最新文章合辑
• Original Research • Previous Articles Next Articles
Received:2025-03-03
Revised:2025-05-18
Published:2026-01-05
Online:2025-12-18
Contact:
LIU Fen
通讯作者:
刘芬
作者简介:作者贡献:
陈玉斐负责研究设计、数据收集与整理、论文初稿撰写、论文修订;赵倩协助研究设计与方案制定,参与现场数据收集,完成部分数据分析,并对论文内容提出修改建议;谢依热·哈木拉提参与统计分析和结果解读,对方法学及讨论部分的撰写提供支持;蔡丽婷参与数据验证和部分章节撰写;李晓梅进行数据质量控制,协助方法部分和讨论部分的内容完善;杨毅宁提供研究的理论与技术支持,指导研究框架构建,协助论文审校和关键内容修订;刘芬负责全面指导研究实施与论文写作,审定最终版本,对文章整体负责。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0671
| 分量表 | 组分 | 测评方法 | LE8指标的量化评分 |
|---|---|---|---|
| 健康行为 | 饮食状况 | 自我报告每日水果、蔬菜、鱼类、豆类、红肉和盐的摄入量 | 水果和蔬菜≥500 g/d:20分 |
| 鱼≥200 g/周:20分 | |||
| 豆类及其制品≥125 g/d:20分 | |||
| 红肉<75 g/d:20分 | |||
| 盐≤6 g/d:20分 | |||
| 体力活动 | 每周自我报告的中等或剧烈体力活动的分钟数 | ≥150 min:100分 | |
| 120~149 min:90分 | |||
| 90~119 min:80分 | |||
| 60~89 min:60分 | |||
| 30~59 min:40分 | |||
| 1~29 min:20分 | |||
| 0 min:0分 | |||
| 尼古丁暴露 | 自我报告的香烟平均每日使用情况 | 从不吸烟:100分 | |
| 戒烟≥5年:75分 | |||
| 戒烟1~5年:50分 | |||
| 戒烟<1年:25分 | |||
| 当前吸烟:0分 | |||
| 睡眠健康 | 自我报告平均每晚睡眠时间 | 7~<9 h:100分 | |
| 9~<10 h:90分 | |||
| 6~<7 h:70分 | |||
| 5~<6 h或≥10 h:40分 | |||
| 4~<5 h:20分 | |||
| <4 h:0分 | |||
| 健康因素 | BMI | 测量并计算 | <23.0 kg/m2:100分 |
| 23.0~24.9 kg/m2:75分 | |||
| 25.0~29.9 kg/m2:50分 | |||
| 30.0~34.9 kg/m2:25分 | |||
| ≥35.0 kg/m2:0分 | |||
| 血脂水平 | 测量血浆总胆固醇和高密度脂蛋白胆固醇,并计算非高密度脂蛋白胆固醇 | <3.36 mmol/L:100分 | |
| 3.36~4.13 mmol/L:60分 | |||
| 4.14~4.90 mmol/L:40分 | |||
| 4.91~5.68 mmol/L:20分 | |||
| ≥5.69 mmol/L:0分 | |||
| 血糖水平 | 测量FBG | 无糖尿病史且FBG<5.6 mmol/L:100分 | |
| 无糖尿病且FBG 5.6~6.9 mmol/L:60分 | |||
| 糖尿病且FBG<8.6 mmol/L:40分 | |||
| 糖尿病且FBG 8.6~10.1 mmol/L:30分 | |||
| 糖尿病且FBG 10.2~11.6 mmol/L:20分 | |||
| 糖尿病且FBG 11.7~13.2 mmol/L:10分 | |||
| 糖尿病且FBG≥13.3 mmol/L:0分 | |||
| 血压水平 | 测量收缩压/舒张压 | <120/80 mmHg:100分 | |
| 120~129/<80 mmHg:75分 | |||
| 130~139/80~89 mmHg:50分 | |||
| 140~159/90~99 mmHg:25分 | |||
| ≥160/100 mmHg:0分 |
Table 1 Definition and quantitative scoring of Life's Essential 8
| 分量表 | 组分 | 测评方法 | LE8指标的量化评分 |
|---|---|---|---|
| 健康行为 | 饮食状况 | 自我报告每日水果、蔬菜、鱼类、豆类、红肉和盐的摄入量 | 水果和蔬菜≥500 g/d:20分 |
| 鱼≥200 g/周:20分 | |||
| 豆类及其制品≥125 g/d:20分 | |||
| 红肉<75 g/d:20分 | |||
| 盐≤6 g/d:20分 | |||
| 体力活动 | 每周自我报告的中等或剧烈体力活动的分钟数 | ≥150 min:100分 | |
| 120~149 min:90分 | |||
| 90~119 min:80分 | |||
| 60~89 min:60分 | |||
| 30~59 min:40分 | |||
| 1~29 min:20分 | |||
| 0 min:0分 | |||
| 尼古丁暴露 | 自我报告的香烟平均每日使用情况 | 从不吸烟:100分 | |
| 戒烟≥5年:75分 | |||
| 戒烟1~5年:50分 | |||
| 戒烟<1年:25分 | |||
| 当前吸烟:0分 | |||
| 睡眠健康 | 自我报告平均每晚睡眠时间 | 7~<9 h:100分 | |
| 9~<10 h:90分 | |||
| 6~<7 h:70分 | |||
| 5~<6 h或≥10 h:40分 | |||
| 4~<5 h:20分 | |||
| <4 h:0分 | |||
| 健康因素 | BMI | 测量并计算 | <23.0 kg/m2:100分 |
| 23.0~24.9 kg/m2:75分 | |||
| 25.0~29.9 kg/m2:50分 | |||
| 30.0~34.9 kg/m2:25分 | |||
| ≥35.0 kg/m2:0分 | |||
| 血脂水平 | 测量血浆总胆固醇和高密度脂蛋白胆固醇,并计算非高密度脂蛋白胆固醇 | <3.36 mmol/L:100分 | |
| 3.36~4.13 mmol/L:60分 | |||
| 4.14~4.90 mmol/L:40分 | |||
| 4.91~5.68 mmol/L:20分 | |||
| ≥5.69 mmol/L:0分 | |||
| 血糖水平 | 测量FBG | 无糖尿病史且FBG<5.6 mmol/L:100分 | |
| 无糖尿病且FBG 5.6~6.9 mmol/L:60分 | |||
| 糖尿病且FBG<8.6 mmol/L:40分 | |||
| 糖尿病且FBG 8.6~10.1 mmol/L:30分 | |||
| 糖尿病且FBG 10.2~11.6 mmol/L:20分 | |||
| 糖尿病且FBG 11.7~13.2 mmol/L:10分 | |||
| 糖尿病且FBG≥13.3 mmol/L:0分 | |||
| 血压水平 | 测量收缩压/舒张压 | <120/80 mmHg:100分 | |
| 120~129/<80 mmHg:75分 | |||
| 130~139/80~89 mmHg:50分 | |||
| 140~159/90~99 mmHg:25分 | |||
| ≥160/100 mmHg:0分 |
| 变量 | 男(n=1 253) | 女(n=1 619) | t(χ2)值 | P值 |
|---|---|---|---|---|
| 年龄( | 50.8±10.9 | 49.5±10.1 | 3.57 | <0.001 |
| 受教育程度[名(%)] | 8.67a | 0.003 | ||
| 高中及以上 | 300(23.94) | 467(28.84) | ||
| 高中以下 | 953(76.06) | 1 152(71.16) | ||
| 婚姻状况[名(%)] | 39.07a | <0.001 | ||
| 已婚 | 1 189(94.89) | 1 428(88.2) | ||
| 离异/其他 | 64(5.11) | 191(11.8) | ||
| 家庭年收入[名(%)] | 2.69a | 0.101 | ||
| <60 000元 | 803(64.09) | 1 085(67.02) | ||
| ≥60 000元 | 450(35.91) | 534(32.98) | ||
| 饮酒状况[名(%)] | 487.58a | <0.001 | ||
| 饮酒 | 554(44.21) | 140(8.65) | ||
| 从不饮酒/其他 | 699(55.79) | 1 479(91.35) | ||
| LE8评分[名(%)] | 120.60a | <0.001 | ||
| 低分组 | 177(14.12) | 75(4.63) | ||
| 中等分组 | 980(78.21) | 1 268(78.32) | ||
| 高分组 | 96(7.67) | 276(17.05) | ||
Table 2 Comparison of the basic characteristics and LE8 scores of residents of different sex
| 变量 | 男(n=1 253) | 女(n=1 619) | t(χ2)值 | P值 |
|---|---|---|---|---|
| 年龄( | 50.8±10.9 | 49.5±10.1 | 3.57 | <0.001 |
| 受教育程度[名(%)] | 8.67a | 0.003 | ||
| 高中及以上 | 300(23.94) | 467(28.84) | ||
| 高中以下 | 953(76.06) | 1 152(71.16) | ||
| 婚姻状况[名(%)] | 39.07a | <0.001 | ||
| 已婚 | 1 189(94.89) | 1 428(88.2) | ||
| 离异/其他 | 64(5.11) | 191(11.8) | ||
| 家庭年收入[名(%)] | 2.69a | 0.101 | ||
| <60 000元 | 803(64.09) | 1 085(67.02) | ||
| ≥60 000元 | 450(35.91) | 534(32.98) | ||
| 饮酒状况[名(%)] | 487.58a | <0.001 | ||
| 饮酒 | 554(44.21) | 140(8.65) | ||
| 从不饮酒/其他 | 699(55.79) | 1 479(91.35) | ||
| LE8评分[名(%)] | 120.60a | <0.001 | ||
| 低分组 | 177(14.12) | 75(4.63) | ||
| 中等分组 | 980(78.21) | 1 268(78.32) | ||
| 高分组 | 96(7.67) | 276(17.05) | ||
| 变量 | 非高血压(n=1 332) | 高血压(n=1 540) | t(χ2)值 | P值 |
|---|---|---|---|---|
| 年龄( | 45.4±8.6 | 54.1±10.3 | 24.44 | <0.001 |
| 性别[名(%)] | 50.44a | <0.001 | ||
| 男 | 487(36.56) | 766(49.74) | ||
| 女 | 845(63.44) | 774(50.26) | ||
| 受教育程度[名(%)] | 8.40a | 0.004 | ||
| 高中及以上 | 390(29.28) | 377(24.48) | ||
| 高中以下 | 942(70.72) | 1 163(75.52) | ||
| 婚姻状况[名(%)] | 53.12a | <0.001 | ||
| 已婚 | 1 252(93.99) | 1 365(88.64) | ||
| 离异/其他 | 80(6.01) | 175(11.36) | ||
| 家庭年收入[名(%)] | 0.02a | 0.898 | ||
| <60 000元 | 874(65.62) | 1 014(65.84) | ||
| ≥60 000元 | 458(34.38) | 526(34.16) | ||
| 饮酒状况[名(%)] | 0.03a | 0.852 | ||
| 饮酒 | 324(24.32) | 370(24.03) | ||
| 从不饮酒/其他 | 1 008(75.68) | 1 170(75.97) | ||
Table 3 Comparison of the basic characteristics of residents with or without hypertension
| 变量 | 非高血压(n=1 332) | 高血压(n=1 540) | t(χ2)值 | P值 |
|---|---|---|---|---|
| 年龄( | 45.4±8.6 | 54.1±10.3 | 24.44 | <0.001 |
| 性别[名(%)] | 50.44a | <0.001 | ||
| 男 | 487(36.56) | 766(49.74) | ||
| 女 | 845(63.44) | 774(50.26) | ||
| 受教育程度[名(%)] | 8.40a | 0.004 | ||
| 高中及以上 | 390(29.28) | 377(24.48) | ||
| 高中以下 | 942(70.72) | 1 163(75.52) | ||
| 婚姻状况[名(%)] | 53.12a | <0.001 | ||
| 已婚 | 1 252(93.99) | 1 365(88.64) | ||
| 离异/其他 | 80(6.01) | 175(11.36) | ||
| 家庭年收入[名(%)] | 0.02a | 0.898 | ||
| <60 000元 | 874(65.62) | 1 014(65.84) | ||
| ≥60 000元 | 458(34.38) | 526(34.16) | ||
| 饮酒状况[名(%)] | 0.03a | 0.852 | ||
| 饮酒 | 324(24.32) | 370(24.03) | ||
| 从不饮酒/其他 | 1 008(75.68) | 1 170(75.97) | ||
| LE8评分体系 | 非高血压(n=1 332) | 高血压(n=1 540) | t值 | P值 |
|---|---|---|---|---|
| 健康行为 | 70.53±14.11 | 67.00±15.68 | 6.07 | <0.001 |
| 饮食状况 | 26.58±14.17 | 25.00±13.82 | 3.01 | 0.003 |
| 体力活动 | 80.28±39.07 | 72.47±43.96 | 5.00 | <0.001 |
| 尼古丁暴露 | 84.74±35.23 | 81.44±37.30 | 2.42 | 0.016 |
| 睡眠健康 | 90.56±18.14 | 89.09±19.71 | 2.07 | 0.038 |
| 健康因素 | 68.22±17.34 | 59.14±17.74 | 13.82 | <0.001 |
| BMI | 52.44±25.78 | 39.04±25.21 | 14.05 | <0.001 |
| 血脂水平 | 60.86±33.36 | 54.44±34.03 | 5.08 | <0.001 |
| 血糖水平 | 91.37±18.11 | 83.95±22.75 | 9.57 | <0.001 |
| LE8 | 69.54±11.33 | 63.63±11.85 | 13.61 | <0.001 |
Table 4 Comparison of the average LE8 score of residents with or without hypertension
| LE8评分体系 | 非高血压(n=1 332) | 高血压(n=1 540) | t值 | P值 |
|---|---|---|---|---|
| 健康行为 | 70.53±14.11 | 67.00±15.68 | 6.07 | <0.001 |
| 饮食状况 | 26.58±14.17 | 25.00±13.82 | 3.01 | 0.003 |
| 体力活动 | 80.28±39.07 | 72.47±43.96 | 5.00 | <0.001 |
| 尼古丁暴露 | 84.74±35.23 | 81.44±37.30 | 2.42 | 0.016 |
| 睡眠健康 | 90.56±18.14 | 89.09±19.71 | 2.07 | 0.038 |
| 健康因素 | 68.22±17.34 | 59.14±17.74 | 13.82 | <0.001 |
| BMI | 52.44±25.78 | 39.04±25.21 | 14.05 | <0.001 |
| 血脂水平 | 60.86±33.36 | 54.44±34.03 | 5.08 | <0.001 |
| 血糖水平 | 91.37±18.11 | 83.95±22.75 | 9.57 | <0.001 |
| LE8 | 69.54±11.33 | 63.63±11.85 | 13.61 | <0.001 |
| LE8评分体系 | 非高血压(n=1 332) | 高血压(n=1 540) | χ2值 | P值 |
|---|---|---|---|---|
| 健康行为评分 | 34.46 | <0.001 | ||
| 低分组 | 99(7.43) | 196(12.73) | ||
| 中等分组 | 648(48.65) | 800(51.95) | ||
| 高分组 | 585(43.92) | 544(35.32) | ||
| 健康因素评分 | 150.90 | <0.001 | ||
| 低分组 | 188(14.11) | 451(29.29) | ||
| 中等分组 | 753(56.53) | 870(56.49) | ||
| 高分组 | 391(29.36) | 219(14.22) | ||
| LE8评分 | 122.93 | <0.001 | ||
| 低分组 | 62(4.66) | 190(12.34) | ||
| 中等分组 | 1 015(76.20) | 1 233(80.06) | ||
| 高分组 | 255(19.14) | 117(7.60) | ||
Table 5 Comparison of the LE8 score grouping of residents with or without hypertension
| LE8评分体系 | 非高血压(n=1 332) | 高血压(n=1 540) | χ2值 | P值 |
|---|---|---|---|---|
| 健康行为评分 | 34.46 | <0.001 | ||
| 低分组 | 99(7.43) | 196(12.73) | ||
| 中等分组 | 648(48.65) | 800(51.95) | ||
| 高分组 | 585(43.92) | 544(35.32) | ||
| 健康因素评分 | 150.90 | <0.001 | ||
| 低分组 | 188(14.11) | 451(29.29) | ||
| 中等分组 | 753(56.53) | 870(56.49) | ||
| 高分组 | 391(29.36) | 219(14.22) | ||
| LE8评分 | 122.93 | <0.001 | ||
| 低分组 | 62(4.66) | 190(12.34) | ||
| 中等分组 | 1 015(76.20) | 1 233(80.06) | ||
| 高分组 | 255(19.14) | 117(7.60) | ||
| 分组 | 模型1 | 模型2 | 模型3 | |||
|---|---|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 健康行为评分(以低分组为参照) | ||||||
| 中等分组 | 0.624(0.479~0.811) | <0.001 | 0.832(0.622~1.113) | 0.215 | 0.827(0.618~1.107) | 0.201 |
| 高分组 | 0.470(0.359~0.614) | <0.001 | 0.767(0.567~1.036) | 0.083 | 0.776(0.574~1.050) | 0.100 |
| 健康因素评分(以低分组为参照) | ||||||
| 中等分组 | 0.482(0.396~0.586) | <0.001 | 0.582(0.472~0.718) | <0.001 | 0.582(0.471~0.719) | <0.001 |
| 高分组 | 0.233(0.184~0.296) | <0.001 | 0.347(0.268~0.450) | <0.001 | 0.340(0.262~0.441) | <0.001 |
| LE8评分(以低分组为参照) | ||||||
| 中等分组 | 0.397(0.295~0.535) | <0.001 | 0.561(0.407~0.774) | <0.001 | 0.567(0.411~0.782) | 0.001 |
| 高分组 | 0.146(0.102~0.210) | <0.001 | 0.311(0.209~0.462) | <0.001 | 0.320(0.215~0.475) | <0.001 |
Table 6 Logistic regression analysis of the effect of residents' LE8 score on the prevalence of hypertension
| 分组 | 模型1 | 模型2 | 模型3 | |||
|---|---|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 健康行为评分(以低分组为参照) | ||||||
| 中等分组 | 0.624(0.479~0.811) | <0.001 | 0.832(0.622~1.113) | 0.215 | 0.827(0.618~1.107) | 0.201 |
| 高分组 | 0.470(0.359~0.614) | <0.001 | 0.767(0.567~1.036) | 0.083 | 0.776(0.574~1.050) | 0.100 |
| 健康因素评分(以低分组为参照) | ||||||
| 中等分组 | 0.482(0.396~0.586) | <0.001 | 0.582(0.472~0.718) | <0.001 | 0.582(0.471~0.719) | <0.001 |
| 高分组 | 0.233(0.184~0.296) | <0.001 | 0.347(0.268~0.450) | <0.001 | 0.340(0.262~0.441) | <0.001 |
| LE8评分(以低分组为参照) | ||||||
| 中等分组 | 0.397(0.295~0.535) | <0.001 | 0.561(0.407~0.774) | <0.001 | 0.567(0.411~0.782) | 0.001 |
| 高分组 | 0.146(0.102~0.210) | <0.001 | 0.311(0.209~0.462) | <0.001 | 0.320(0.215~0.475) | <0.001 |
| 模型1 | 模型2 | 模型3 | ||||
|---|---|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 健康行为评分 | ||||||
| 每增加10分 | 0.711(0.633~0.798) | <0.001 | 0.893(0.784~1.018) | 0.091 | 0.899(0.788~1.025) | 0.111 |
| 健康因素评分 | ||||||
| 每增加10分 | 0.483(0.429~0.544) | <0.001 | 0.589(0.517~0.670) | <0.001 | 0.582(0.511~0.663) | <0.001 |
| LE8评分 | ||||||
| 每增加10分 | 0.642(0.600~0.687) | <0.001 | 0.758(0.703~0.817) | <0.001 | 0.757(0.702~0.816) | <0.001 |
Table 7 Logistic regression analysis of the effect of each 10-point increase in residents' LE8 score on the prevalence of hypertension
| 模型1 | 模型2 | 模型3 | ||||
|---|---|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 健康行为评分 | ||||||
| 每增加10分 | 0.711(0.633~0.798) | <0.001 | 0.893(0.784~1.018) | 0.091 | 0.899(0.788~1.025) | 0.111 |
| 健康因素评分 | ||||||
| 每增加10分 | 0.483(0.429~0.544) | <0.001 | 0.589(0.517~0.670) | <0.001 | 0.582(0.511~0.663) | <0.001 |
| LE8评分 | ||||||
| 每增加10分 | 0.642(0.600~0.687) | <0.001 | 0.758(0.703~0.817) | <0.001 | 0.757(0.702~0.816) | <0.001 |
| LE8组分 | 模型1 | 模型2 | ||||||
|---|---|---|---|---|---|---|---|---|
| OR值 | 95%CI | P值 | P趋势值 | OR值 | 95%CI | P值 | P趋势值 | |
| 饮食状况评分(以低分组为参照) | 0.079 | 0.219 | ||||||
| 中等分组 | 0.728 | 0.467~1.136 | 0.162 | 0.804 | 0.499~1.297 | 0.372 | ||
| 高分组 | 0.128 | 0.013~1.237 | 0.076 | 0.167 | 0.016~1.716 | 0.132 | ||
| 体力活动评分(以低分组为参照) | <0.001 | 0.051 | ||||||
| 中等分组 | 0.715 | 0.348~1.469 | 0.361 | 0.719 | 0.338~1.530 | 0.392 | ||
| 高分组 | 0.638 | 0.530~0.769 | <0.001 | 0.779 | 0.635~0.954 | 0.016 | ||
| 尼古丁暴露评分(以低分组为参照) | 0.002 | 0.467 | ||||||
| 中等分组 | 1.758 | 1.079~2.865 | 0.024 | 1.351 | 0.815~2.240 | 0.244 | ||
| 高分组 | 0.827 | 0.667~1.024 | 0.082 | 1.105 | 0.851~1.435 | 0.453 | ||
| 睡眠健康评分(以低分组为参照) | 0.210 | 0.486 | ||||||
| 中等分组 | 0.738 | 0.519~1.051 | 0.092 | 0.813 | 0.559~1.183 | 0.279 | ||
| 高分组 | 0.775 | 0.573~1.049 | 0.099 | 0.824 | 0.597~1.138 | 0.24 | ||
| BMI评分(以低分组为参照) | <0.001 | <0.001 | ||||||
| 中等分组 | 0.459 | 0.389~0.543 | <0.001 | 0.439 | 0.368~0.524 | <0.001 | ||
| 高分组 | 0.257 | 0.190~0.347 | <0.001 | 0.246 | 0.179~0.338 | <0.001 | ||
| 血脂水平评分(以低分组为参照) | 0.106 | 0.744 | ||||||
| 中等分组 | 0.858 | 0.709~1.039 | 0.117 | 0.924 | 0.755~1.131 | 0.443 | ||
| 高分组 | 0.832 | 0.691~1.001 | 0.052 | 0.972 | 0.797~1.186 | 0.78 | ||
| 血糖水平评分(以低分组为参照) | <0.001 | <0.001 | ||||||
| 中等分组 | 0.639 | 0.400~1.022 | 0.062 | 0.757 | 0.463~1.238 | 0.268 | ||
| 高分组 | 0.366 | 0.233~0.575 | <0.001 | 0.506 | 0.315~0.812 | 0.005 | ||
Table 8 Logistic regression analysis of the effect of LE8 component scores on the prevalence of hypertension
| LE8组分 | 模型1 | 模型2 | ||||||
|---|---|---|---|---|---|---|---|---|
| OR值 | 95%CI | P值 | P趋势值 | OR值 | 95%CI | P值 | P趋势值 | |
| 饮食状况评分(以低分组为参照) | 0.079 | 0.219 | ||||||
| 中等分组 | 0.728 | 0.467~1.136 | 0.162 | 0.804 | 0.499~1.297 | 0.372 | ||
| 高分组 | 0.128 | 0.013~1.237 | 0.076 | 0.167 | 0.016~1.716 | 0.132 | ||
| 体力活动评分(以低分组为参照) | <0.001 | 0.051 | ||||||
| 中等分组 | 0.715 | 0.348~1.469 | 0.361 | 0.719 | 0.338~1.530 | 0.392 | ||
| 高分组 | 0.638 | 0.530~0.769 | <0.001 | 0.779 | 0.635~0.954 | 0.016 | ||
| 尼古丁暴露评分(以低分组为参照) | 0.002 | 0.467 | ||||||
| 中等分组 | 1.758 | 1.079~2.865 | 0.024 | 1.351 | 0.815~2.240 | 0.244 | ||
| 高分组 | 0.827 | 0.667~1.024 | 0.082 | 1.105 | 0.851~1.435 | 0.453 | ||
| 睡眠健康评分(以低分组为参照) | 0.210 | 0.486 | ||||||
| 中等分组 | 0.738 | 0.519~1.051 | 0.092 | 0.813 | 0.559~1.183 | 0.279 | ||
| 高分组 | 0.775 | 0.573~1.049 | 0.099 | 0.824 | 0.597~1.138 | 0.24 | ||
| BMI评分(以低分组为参照) | <0.001 | <0.001 | ||||||
| 中等分组 | 0.459 | 0.389~0.543 | <0.001 | 0.439 | 0.368~0.524 | <0.001 | ||
| 高分组 | 0.257 | 0.190~0.347 | <0.001 | 0.246 | 0.179~0.338 | <0.001 | ||
| 血脂水平评分(以低分组为参照) | 0.106 | 0.744 | ||||||
| 中等分组 | 0.858 | 0.709~1.039 | 0.117 | 0.924 | 0.755~1.131 | 0.443 | ||
| 高分组 | 0.832 | 0.691~1.001 | 0.052 | 0.972 | 0.797~1.186 | 0.78 | ||
| 血糖水平评分(以低分组为参照) | <0.001 | <0.001 | ||||||
| 中等分组 | 0.639 | 0.400~1.022 | 0.062 | 0.757 | 0.463~1.238 | 0.268 | ||
| 高分组 | 0.366 | 0.233~0.575 | <0.001 | 0.506 | 0.315~0.812 | 0.005 | ||
| [1] |
Risk Factor Collaboration(NCD-RISC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants[J]. Lancet, 2021, 398(10304): 957-980. DOI: 10.1016/S0140-6736(21)01330-1.
|
| [2] |
COLLABORATORS G 2 R F. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1223-1249. DOI: 10.1016/S0140-6736(20)30752-2.
|
| [3] |
张冬燕,李燕. 世界卫生组织《全球高血压报告》(2023年)概要及解读[J]. 诊断学理论与实践, 2024, 23(3): 297-304. DOI: 10.16150/j.1671-2870.2024.03.007.
|
| [4] |
张媛,侯旗旗,齐祺,等. 基于生命八要素的心血管健康评分与新发心房颤动的关联研究:大样本长期随访研究[J]. 中国全科医学, 2024, 27(12): 1431-1437. DOI: 10.12114/j.issn.1007-9572.2023.0598.
|
| [5] |
World Health Organization. Hypertension [EB/OL]. (2023-11-01)[2024-11-04].
|
| [6] |
顾东风,翁建平,鲁向锋. 中国健康生活方式预防心血管代谢疾病指南[J]. 中国循环杂志, 2020, 35(3): 209-230.
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
中国营养学会肥胖防控分会,中国营养学会临床营养分会,中华预防医学会行为健康分会,等. 中国居民肥胖防治专家共识[J]. 中华流行病学杂志, 2022, 43(5): 609-626.
|
| [21] |
中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压病学分会,等. 中国高血压防治指南(2024年修订版)[J]. 中华高血压杂志:中英文, 2024, 32(7): 603-700.
|
| [22] |
National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management[M]. London: National Institute for Health and Care Excellence, 2023.
|
| [23] |
|
| [24] |
刘明波,何新叶,杨晓红,等. 《中国心血管健康与疾病报告2023》要点解读[J]. 中国全科医学, 2025, 28(1): 20-38.DOI: 10.3969/j.issn.1007-5410.2024.04.002.
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
薛涛涛,王丽敏,赵振平. 基于"生命八要素"评分的中国成年居民心血管健康状况分析[J]. 中华流行病学杂志, 2023, 44(7): 1054-1062.
|
| [33] |
|
| [34] |
|
| [35] |
RISK FACTOR COLLABORATION(NCD-RISC). General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7.5 million participants[J]. Lancet, 2024, 404(10455): 851-863. DOI: 10.1016/S0140-6736(24)01405-3.
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [1] | YANG Caiyi, HU Xiaohai, ZHU Hongjun, XU Yifan. Therapeutic Effect of Chaigu Decoction Combined with Western Medicine on Hypertension with Liver Depression and Blood Deficiency Pattern and Its Serum Metabolomics Analysis [J]. Chinese General Practice, 2026, 29(31): 4589-4599. |
| [2] | WANG Shuaihang, CAO Yedi, CHEN Fei, ZHU Sainan, GAO Ying. The Association between the Weight-adjusted Waist Index and Thyroid Function and Autoimmunity: Insights from NHANES Data [J]. Chinese General Practice, 2026, 29(30): 4406-4414. |
| [3] | WANG Sixue, YUAN Yue, XIONG Lisha, ZHOU Chunyi, YUAN Xiangqing, FANG Xuelian, ZHANG Ailin, WANG Yuncui. Development of the Traditional Chinese Medicine Health Behaviors Stage-specific Influencing Factors Scale and Its Reliability and Validity Testing [J]. Chinese General Practice, 2026, 29(29): 4337-4344. |
| [4] | WANG Dunjian, CHEN Yonggang, HU Bing, ZHAO Hengyi, YANG Qing. Application of Home-based Medication Therapy Management in Contracted Patients with Diabetes and Hypertension: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(29): 4226-4231. |
| [5] | WANG Lin, CAO Chenchen, HUANG Yichong, LIU Jing. Development of Preference Attributes and Levels of Family Doctor Contract Services for Patients with Comorbidity of Hypertension and Type 2 Diabetes Mellitus Based on Discrete Choice Experiments [J]. Chinese General Practice, 2026, 29(29): 4232-4240. |
| [6] | YUAN Yue, WANG Sixue, YUAN Xiangqing, ZHOU Chunyi, XIONG Lisha, ZHANG Ailin, FANG Xuelian, WANG Yuncui. Development Reliability Validity Test of Traditional Chinese Medicine Health Behaviors Scale [J]. Chinese General Practice, 2026, 29(26): 3865-3872. |
| [7] | YANG Rui, LIAO Xiaoyang, HUANG Chuanying, YANG Ziyu, SHEN Can, JIA Yu, LIU Lidi, YANG Rong. Interpretation of the 2024 British and Irish Hypertension Society Position Statement: Investigation and Management of Hypertension in Young People [J]. Chinese General Practice, 2026, 29(26): 3726-3732. |
| [8] | LI Xiaoxue, YIN Lihua, SU Xu, ZHANG Fuyan, ZHAN Qingqing, AN Qinyu, WANG Huiqun, LIU Tao, TAN Shisheng. Association between Dietary Quality and Risk of Hypertension: a Study Based on the 2022 Version of the Chinese Dietary Balance Index [J]. Chinese General Practice, 2026, 29(25): 3631-3639. |
| [9] | XUE Cuirong, WEI Wei, WU Renyuan, XUE Yaqin, XU Huijiang, LYU Weijiang, JIANG Dandan. Prevalence and Management Status of Chronic Kidney Disease in Hypertensive and Type 2 Diabetic Populations: a Community-based Cross-sectional Study [J]. Chinese General Practice, 2026, 29(25): 3650-3654. |
| [10] | ZHANG Wenzheng, ZHANG Hongling. Association between Cardiometabolic Index and Hypertension in Elderly Patients with Metabolic Associated Fatty Liver Disease in the Community Population: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(23): 3261-3267. |
| [11] | ZHOU Xiaoya, WANG Weikai, LIU Qian, LI Jianhua, SUN Bo, WANG Yanxia. Study of the Interaction between Sleep Quality and Melatonin Receptor 1B Gene Polymorphism on Gestational Hypertension [J]. Chinese General Practice, 2026, 29(21): 2975-2981. |
| [12] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [13] | LIU Ying, LIU Shiwei, ZHANG Chi, SHEN Ji, ZHANG Yushan, ZHANG Jie, SANG Yingchen, WANG Youjiao, WANG Lei, ZHOU Houguang, SHI Hong. Prevalence and Associated Factors of Subjective Cognitive Decline among Older Stroke Patients in China [J]. Chinese General Practice, 2026, 29(20): 2829-2835. |
| [14] | ZHANG Xiaojuan, LIU Yang, PENG Bo, YE Yuan, ZHU Kun. Study on the Prevention and Treatment of Hypertension and Diabetes Mellitus in Community Hospital [J]. Chinese General Practice, 2026, 29(19): 2614-2620. |
| [15] | MIAO Jingjie, ZHANG Jinwen, WU Qianhao, HAN Peipei. Research Advances on the Effects of Intermittent Fasting on Cardiometabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2538-2545. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||